US Stock MarketDetailed Quotes

SWTX SpringWorks Therapeutics

Watchlist
  • 38.040
  • +1.170+3.17%
Close Jul 26 16:00 ET
  • 38.040
  • 0.0000.00%
Post 20:02 ET
2.82BMarket Cap-7386P/E (TTM)

SpringWorks Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SpringWorks Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 7, 2024

Revenue(YoY)

34.58M

0.00%
EPS(YoY)

-1.12

+10.77%
Analyst Rating

Strong Buy

Jun 30, 2024

SpringWorks Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 43.829M--
Aug 7, 20242024/Q2-- / 34.580M--
May 2, 20242024/Q121.006M / 13.068M--
--2023/Q45.447M / 903.330K--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 43.829M--
Aug 7, 20242024/Q2-- / 34.580M--
May 2, 20242024/Q121.006M / 13.068M--
--2023/Q45.447M / 903.330K--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

SpringWorks Therapeutics Earnings Reports

  • SpringWorks Therapeutics | 10-Q: Quarterly report

    May 2 06:33 ET

  • SpringWorks Therapeutics | 10-K: Annual report

    Feb 27 06:55 ET

  • SpringWorks Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 06:38 ET

  • SpringWorks Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 06:36 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg